Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)

Main Category: Diabetes
Article Date: 12 Jun 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (3 votes)

Healthcare Prof:not yet rated


The latest issue of the online journal Diabetic Hypoglycemia features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy.

Professor Campbell's review focuses on sulfonylurea-induced hypoglycemia (SIH), which is a well-recognized side-effect of this class of therapy for type 2 diabetes. In the review he discusses the incidence of SIH, with particular reference to the different sulfonylureas. He also reflects on the morbidity and mortality seen with SIH, precipitating risk factors, treatment of SIH, and education of patients and medical staff in the prevention of SIH.

This issue of Diabetic Hypoglycemia also includes a case study on recurring hypoglycemia associated with glibenclamide, by Professor Campbell.

Dr Rory McCrimmon of the Editorial Board reviews the literature on blood glucose monitoring in hypoglycemia, in an editorial entitled 'What we're learning from continuous glucose monitoring'.

This issue of Diabetic Hypoglycemia also features an 'In profile' interview with Professor Stephanie Amiel, a leading expert in the use of neuroimaging in diabetes and hypoglycemia.

About the Journal

Diabetic Hypoglycemia is an influential online diabetes journal. The Editorial Board of hypoglycemia experts peer review all Journal content. The Board is led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA) and Dr Rory McCrimmon (Yale, USA). Diabetic Hypoglycemia is published three times a year, providing an interactive forum for readers to share practical knowledge and opinions on the rapidly evolving field of hypoglycemia.

To explore the Diabetic Hypoglycemia website and its key features, our guided tour can be activated by clicking the following link here.

Diabetic Hypoglycemia is published by ESP Bioscience. Support for the journal is provided by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).

Source
ESP Bioscience


Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Diabetic Hypoglycemia. "Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)." Medical News Today. MediLexicon, Intl., 12 Jun. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/153505.php>

APA
Diabetic Hypoglycemia. (2009, June 12). "Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/153505.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »